Literature DB >> 29713466

Dissemination of blaNDM-5 gene via an IncX3-type plasmid among non-clonal Escherichia coli in China.

Xi Li1, Ying Fu2, Mengyuan Shen1, Danyan Huang3, Xiaoxing Du3, Qingfeng Hu1, Yonglie Zhou1, Dairong Wang4, Yunsong Yu3.   

Abstract

Background: The emergence and spread of New Delhi metallo-β-lactamase-producing Enterobacteriaceae has been a serious challenge to manage in the clinic due to its rapid dissemination of multi-drug resistance worldwide. As one main type of carbapenemases, New Delhi metallo-β-lactamase (NDM)is able to confer resistance to almost all β-lactams, including carbapenems, in Enterobacteriaceae. Recently, New Delhi metallo-β-lactamase-5 attracted extensive attention because of increased resistance to carbapenems and widespread dissemination. However, the dissemination mechanism of blaNDM-5 gene remains unclear.
Methods: A total of 224 carbapenem-resistant Enterobacteriaceae isolates (CRE) were collected from different hospitals in Zhejiang province. NDM-5-positive isolates were identified and subjected to genotyping, susceptibility testing, and clinical data analysis. We established the genetic location of blaNDM-5 with southern blot hybridisation, and analysed plasmids containing blaNDM-5 with filter mating and DNA sequencing.
Results: Eleven New Delhi metallo-β-lactamase-5 (NDM-5)-producing strains were identified, including 9 Escherichia coli strains, 1 Klebsiella pneumoniae strain, and 1 Citrobacter freundii strain. No epidemiological links for E. coli isolates were identified by multilocus sequence typing (MLST) and pulsed-field gel electrophoresis (PFGE). S1-PFGE and southern blot suggested that the blaNDM-5 gene was located on a 46-kb IncX3-type plasmid in all isolates. Nine of the 11 isolates (81.8%) tested could successfully transfer their carbapenem-resistant phenotype to E. coli strain C600. Moreover, sequence analysis further showed that this plasmid possessed high sequence similarity to most of previously reported blaNDM-5-habouring plasmids in China.
Conclusion: The present data in this study showed the IncX3 type plasmid played an important role in the dissemination of blaNDM-5 in Enterobacteriaceae. In addition, to the best of our knowledge, this report is the first to isolate both E. coli and C. freundii strains carrying blaNDM-5 from one single patient, which further indicated the possibility of blaNDM-5 transmission among diverse species. Close surveillance is urgently needed to monitor the further dissemination of NDM-5-producing isolates.

Entities:  

Keywords:  Carbapenem resistance; Enterobacteriaceae; IncX3 type plasmid; blaNDM-5

Mesh:

Substances:

Year:  2018        PMID: 29713466      PMCID: PMC5918551          DOI: 10.1186/s13756-018-0349-6

Source DB:  PubMed          Journal:  Antimicrob Resist Infect Control        ISSN: 2047-2994            Impact factor:   4.887


Background

Enterobacteriaceae, such as E.coli, K. pneumoniae and C. freundii, are important pathogens that cause human infections. Carbapenem antibiotics are used in the treatment of infections caused by multi-drug resistant Enterobacteriaceae. However, the emergence of Carbapenem-resistant Enterobacteriaceae (CRE) has been a serious challenge to manage in the clinic because of the rapid worldwide dissemination of multi-drug resistance [1]. As one main type of carbapenemases, New Delhi metallo-β-lactamase (NDM)is able to confer resistance to almost all β-lactams, including carbapenems, in Enterobacteriaceae. Since the first report of blaNDM-1, 17 variants of NDM enzymes (NDM-1 to NDM-17) have been identified among Gram-negative bacteria worldwide (http://www.ncbi.nlm.nih.gov/pathogens/submit_beta_lactamase/). Among NDM carbapenemases, New Delhi metallo-β-lactamase-5, first identified in an E. coli strain in the UK in 2011, attracted extensive attention because of increased resistance to carbapenems and broad-spectrum cephalosporins [2]. In addition, blaNDM-5 was reported to be carried in different incompatibility typing plasmids to transfer [3], such as IncF, IncN and IncX3. These plasmids are able to facilitate the dissemination of blaNDM-5 among the members of Enterobacteriaceae through horizontal gene transfer. NDM-5-producing isolates have been identified worldwide, such as in America [4], Australia [5], China [6], Denmark [7] and India [8]. Furthermore, NDM-5-positive strains were not only isolated from clinical specimens but also from animals, such as dogs [9], cats [10] and cows [11]. Worryingly, blaNDM-5 has also been identified in environmental samples [hospital sewage water [12] and urban river [13]], indicating its presence in the community. However, the dissemination mechanism of blaNDM-5 gene remains unclear. In this study, we screened NDM-5-producing Enterobacteriaceae to elucidate the dissemination mechanism. In addition, to the best of our knowledge, this report is the first to isolate E. coli and C. freundii strains carrying blaNDM-5 from the same patient.

Methods

Bacterial strains

From Jun. 2016 to Sep. 2017, 224 carbapenem-resistant Enterobacteriaceae isolates, as determined by the agar dilution method according to the Clinical and Laboratory Standards Institute guidelines [14], were obtained from four hospitals in different locations in Zhejiang, China. In a retrospective study, common carbapenemase genes (blaKPC, blaIMP, blaVIM, blaOXA-48, and blaNDM) were amplified, and the positive products were sequenced; eleven NDM-5 producing strains were identified for further study. The NDM-5 producing strains were preliminarily identified by the VITEK 2 system (Sysmex-bioMérieux, Marcy l’Etoile, France) and further confirmed by whole genome sequencing. The characteristics of the isolates and related clinical data are shown in Table 1.
Table 1

Clinical characteristics

IsolatesDate of hospitalizationDate of isolationPatient SexPatient Age (years)Clinical SampleHospital WardClinical DiagnosisAntimicrobial TherapyOutcome
EC1352016/5/272016/6/20Male85SputumICUAcute renal failureCPS, LEVDeath
KP3872017/6/72017/6/26Male40bloodHematologyMyelodysplastic syndromesTGC, LEV, AMKAlive
EC1262016/7/292016/8/10Female76urineSurgeryUracratiaCPS, TGCAlive
EC7342016/7/272016/9/9Female61pusICUKidney neoplasmsCPS, IMP, LEV, TGCDeath
EC4632016/10/72016/10/24Male16bloodHematologyAcute lymphoblastic leukemiaAMK, IMP, TZPAlive
EC1442016/10/242016/11/3Female50ascitesSurgeryGastric cancerCPS, AMKAlive
EC1222017/5/52017/5/23Male69urineICUAspiration pneumoniaTZP, CPS, LEVAlive
EC6112017/6/122017/7/5Male72ascitesSurgeryColonic neoplasmsTZP, CPS, IMPAlive
EC4182017/7/112017/7/22Female27fecesHematologyAcute myelogenous leukemiaIMP, MEM, LEVAlive
CF4182017/7/112017/7/22Female27fecesHematologyAcute myelogenous leukemiaIMP, MEM, LEVAlive
EC3102017/6/202017/7/29Female55bloodInfectious DiseaseBiliary tract infectionCPS, IMP, LEV, ATM, AMK, TGCAlive

MNO minocycline, MEM meropenem, LEV levofloxacin, TZP piperacillin/tazobactam, CPS cefperazone/sulbactam, TGC tigecycline, IMP imipenem, AMK amikacin

Clinical characteristics MNO minocycline, MEM meropenem, LEV levofloxacin, TZP piperacillin/tazobactam, CPS cefperazone/sulbactam, TGC tigecycline, IMP imipenem, AMK amikacin

Antimicrobial susceptibility testing

Antimicrobial susceptibility testing was performed using broth microdilution method [14]. The antibiotics tested in this study were amikacin, aztreonam, cefepime, ceftazidime, ciprofloxacin, gentamicin, imipenem, minocycline, colistin and tigecycline. The results were analysed according to the CLSI guidelines [14], except tigecycline and colistin, for which the European Committee on Antimicrobial Susceptibility Testing breakpoints were used (http://www.eucast.org/clinical_breakpoints). E. coli ATCC 25922 was used as a quality control strain.

Bacterial genotyping

Pulsed-field gel electrophoresis (PFGE) was performed to analyse the clonal relatedness of the NDM-5 producing E. coli isolates according to the previous study [15]. Briefly, the isolates were digested by XbaI endonuclease, which was carried out with a CHEF-Mapper XA PFGE system (Bio-Rad, USA) with a 5–35 s linear ramp for 22 h at 6 V/cm and 14 °C. The PFGE profiles were analyzed with BioNumerics software (Applied Maths, Sint-Martens-Latern, Belgium). The Salmonella enterica serotype Braenderup H9812 was used as the size marker. MLST was also performed for molecular typing. Bacterial genomic DNA was extracted from these isolates. Seven housekeeping genes of E. coli (adk, fumC, gyrB, icd, mdh, purA and recA), and K. pneumoniae (gapa, infb, mdh, pgi, phoe, rpob) were amplified by PCR, and the products were sequenced to analyse the ST.

Southern blot analysis and conjugation experiments

To determine the plasmid location of the blaNDM-5 gene, genomic DNA digested with S1-nuclease (TaKaRa, Japan) was electrophoresed on a CHEF-mapper XA pulsed-field gel electrophoresis (PFGE) system (Bio-Rad, USA) for 18 h at 14 °C with run conditions of 6 V/cm and pulse times from 2.16 s to 63.8 s. The DNA fragments were transferred to a positive-charged nylon membrane (Millipore, USA) and then hybridized with a digoxigenin-labeled NDM-5-specific probe. An NBT/BCIP color detection kit (Roche, Germany) was then used to detect the fragments. The Salmonella enterica serotype Braenderup H9812 was used as the size marker. A filter-mating experiment was performed between the blaNDM-5-positive isolates and rifampicin-resistant E. coli C600 as the recipient strain [15]. Transconjugants were selected on Mueller-Hinton agar plates containing 500 mg/L rifampicin and 100 mg/L ampicillin. PCR sequencing and antimicrobial susceptibility testing of the transconjugants were subsequently carried out to confirm whether the plasmid was successfully transferred to the recipient.

Plasmids analysis

Plasmid extraction and analysis was performed as previously described [15]. Briefly, the plasmid DNA of strains was extracted using a QIAamp DNA MiniKit (Qiagen, Valencia, CA, USA) following the manufacturer’s recommendations. The plasmids were sequenced on an Illumina-Hiseq™ 2000 (Illumina Inc., San Diego, U.S.A) platform with 2 × 100 bp paired-end reads. Sequence reads were assembled using CLC Genomics Workbench software package (CLC Bio 8.0). Gaps of a representative plasmid were closed by standard PCR and Sanger sequencing according to previous study [16]. The RAST (Rapid Annotation using Subsystems Technology) annotation website server (http://rast.nmpdr.org/rast.cgi) was then used to annotate the genomes of the plasmid. The circular map of the pEC463-NDM5 plasmid was generated using the CGview server [17]. A comparison of pEC463-NDM5 and three related plasmids was performed with EasyFig 2.2.2 [18]. The rested plasmid sequences were mapped to the representative plasmid sequence with CLC genomics workbench version 8.0. Incompatibility typing of the blaNDM plasmid was performed by PCR-based replicon typing [19, 20] and was further identified with the help of PlasmidFinder-1.3 server (https://cge.cbs.dtu.dk/services/PlasmidFinder/). In addition, plasmid stability was determined [3]. Briefly, the blaNDM-5-positive isolates were individually streaked out in the MH agar, incubated at 37 °C for 24 h, and then transferred to a fresh MH agar. After repeating this procedure for 12 days, 12 individual colonies were randomly selected. Subsequently, the blaNDM-5 gene was screened by PCR and sequenced.

Nucleotide sequence accession number

The complete sequence of the plasmid pEC463-NDM5 (accession number MG545911), is deposited at DDBJ/EMBL/GenBank.

Results and discussion

Isolate characteristics and antimicrobial susceptibility testing

Among the 224 CRE isolates, 137 isolates were KPC-2 carbapenemase producers, eleven isolates were NDM-5 carbapenemase producers, four isolates carried blaIMP-1 gene, two isolates carried blaVIM-1 gene and two isolates carried blaNDM-1 gene. In addition, 68 isolates exited other unknown mechanism of carbapenem-resistance. In this study, eleven NDM-5-producing isolates were further identified, including nine E. coli, one K. pneumoniae and one C. freundii. These isolates were all recovered from hospitalized patients. These patients were aged between 16 and 85 years, with an average age of 55 years, had different severities of illness (Table 1), and all had previously received broad-spectrum antibiotics. Notably, with both E. coli (EC418) and C. freundii strains (CF418) were isolated from the feces of one patient from haematology department. This patient was found to be a carrier of blaNDM-5-positive strains. In contrast, the other patients from whom blaNDM-5-carrying strains were isolated from blood, pus, ascites, urine or sputum were symptomatic. In addition, these patients had no recent history of travel or hospitalization abroad. The antimicrobial susceptibility testing results showed that the blaNDM-5-positive isolates were resistant to carbapenems, third-generation cephalosporins, and cefperazone/sulbactam. These isolates were also resistant to fluoroquinolones (81.8%), aztreonam (36.4%), amikacin (36.4%), nitrofurantoin (45.4%) and tigecycline (18.2%). All isolates were susceptible to colistin. E.coli EC122 and K. pneumoniae KP387 strains were both resistant to tigecycline, suggesting that increased resistance phenotypes of blaNDM-5-postive isolates are increasing in clinics. In addition, other β-lactamase genes, such as those encoding CTX-M-24, CTX-M-55, CMY-42, were also frequently detected in various blaNDM-5-positive E. coli strains (Fig. 1). Gene encoding SHV-1 and CMY-26 were detected in the K. pneumoniae KP387 and C. freundii CF418 strains, respectively.
Fig. 1

The dendrogram is based on the similarity of PFGE patterns from 9 blaNDM-5 positive clinical E. coli isolates. The right illustrates results from MLST, hospitals and β-lactamase gene(s)

The dendrogram is based on the similarity of PFGE patterns from 9 blaNDM-5 positive clinical E. coli isolates. The right illustrates results from MLST, hospitals and β-lactamase gene(s) S1-digested plasmid DNA and southern blot hybridization of blaNDM-5 positive isolates. Bands in A with arrows pointing to them showed positive signals in Southern blot hybridization with the NDM-5 probe. M = Salmonella serotype Braenderup strain H9812 molecular marker. 1 = K. pneumoniae KP387; 2 = E. coli EC135; 3 = E. coli EC463; 4 = E. coli EC734; 5 = E. coli EC144; 6 = E. coli EC122; 7 = E. coli EC418; 8 = C. freundii CF418; 9 = E. coli EC310; 10 = E. coli EC611; 11 = E. coli EC126 Our recent studies showed that blaNDM-5 was able to coexist in the same isolate with tigecycline and colistin resistance phenotypes, thereby generating strains that approached pan-resistance. For example, blaNDM-5 was not only identified in high-level tigecycline resistance E. coli strains [21], but also coexisted in the same strain with the transferrable colistin resistance gene mcr-1 [15]. It is clear that generating strains results in so-called “superbug” isolates and accelerating entery into a “postantibiotic” era [22].

Genetic relatedness

MLST and PFGE experiments were performed to analyse the clonal relatedness of blaNDM-5-positive isolates because NDM-5 producers are infrequently isolated worldwide. According to the MLST results, nine blaNDM-5-postive E. coli isolates were grouped into 9 different sequence types. In accordance with the MLST results (Fig. 1), the different PFGE patterns confirmed that the seven E. coli isolates are not clonally related to each other even though some of the strains were collected from the same hospital. Strains EC122 and EC144 own similar the PFGE profiles, but the two strains have different sequence type and different resistance genes. Furthermore, core genome multi-locus sequence typing (cg-MLST) analysis in our study showed the blaNDM-5-positive isolates were not clonal relatedness (Additional file 1: Figure S1). In addition, the K. pneumoniae KP487 isolate belongs to ST182. A previous study collected 11 NDM-5-producing E. coli strains from 7 hospitals in various locations in China from 2013 to 2014, and found that ST167 E. coli strains in clinical settings exhibited close linkages with the blaNDM-5 gene [23]. Our previous study also showed that high-level tigecycline resistance E. coli strains carrying blaNDM-5 also belonged to the ST167 clonal lineage [21], indicating that the ST167 sequence type is an important reservoir of blaNDM-5 in China. However, the diversity of MLST and PFGE types in the present study showed that the blaNDM-5 gene has been carried in other STs E. coli isolates from 2016 to 2017. Moreover, the blaNDM-5 gene was detected in the K. pneumoniae and one C. freundii strains, indicating that this gene has further disseminated in Enterobacteriaceae. Note that NDM-5-related outbreak has been reported [24, 25]. Although no genetic association was found between our blaNDM-5-positive isolates with other strains, the widespread dissemination of blaNDM-5 in recent years in Enterobacteriaceae highlights the need for extensive attention.

Location of the blaNDM-5 gene

S1-PFGE followed by Southern blot demonstrated that the blaNDM-5-positive strains were all located on plasmids of the same size(~ 46 Kb) (Fig. 2). The filter mating experiments were carried out to confirm the transferability of these blaNDM-5 plasmids. Nine of the 11 isolates tested could successfully transfer their carbapenem-resistant phenotype to E. coli strain C600 (Table 2). In addition,incompatibility plasmid classification showed that all the blaNDM-5 plasmids belonged to the IncX3-type plasmid. IncX3 plasmids might have played an important role in mediating the horizontal transmission of the blaNDM gene. This possibility has been supported by the results of several studies [6, 26–29]. In this study, blaNDM-5 was carried by the IncX3 plasmids. Moreover, 81.8% (9/11) of isolates carrying this type plasmid were able to transfer carbapenem-resistant phenotype. However, conjugation experiments of E. coli EC126 and EC135 strains were not performed because these two strains were resistant to rifampin. To date, IncX3 plasmids carrying blaNDM-5 have been reported worldwide [3, 22, 23]. Therefore, our present study further supplements those previous studies. In addition, we isolated E. coli and C. freundii strains carrying blaNDM-5 from a single patient. These blaNDM-5-carrying plasmids had very similar sequences (99% coverage and 98% similarity), indicating probable horizontal transfer of blaNDM-5 between E. coli and C. freundii strains by one same plasmid. In addition, the plasmid stability experiments showed that the blaNDM-5-positive plasmids were all stable in these isolates. After 12 rounds of subculture in MH agar without antibiotic addition, the randomly selected strains all carried the blaNDM-5 gene and a plasmid identical to their parental isolate in size. Overall, it is important for the IncX3 type plasmid to play an important role in the further dissemination of blaNDM-5 in Enterobacteriaceae. Therefore, it is imperative that effective measures be taken immediately to control the spread of this plasmid.
Fig. 2

S1-digested plasmid DNA and southern blot hybridization of blaNDM-5 positive isolates. Bands in A with arrows pointing to them showed positive signals in Southern blot hybridization with the NDM-5 probe. M = Salmonella serotype Braenderup strain H9812 molecular marker. 1 = K. pneumoniae KP387; 2 = E. coli EC135; 3 = E. coli EC463; 4 = E. coli EC734; 5 = E. coli EC144; 6 = E. coli EC122; 7 = E. coli EC418; 8 = C. freundii CF418; 9 = E. coli EC310; 10 = E. coli EC611; 11 = E. coli EC126

Table 2

Antibiotic susceptibility of NMD5-producing isolates and their transconjugants

IsolatesMICs (mg/L)
FEPIPMNITCAZAMKCIPATMTGCCPS2/1MNOCOL
EC126> 1288128> 128> 128128> 1280.5> 25680.5
EC135641664> 1281281280.1252> 256320.5
KP3876416128> 128120.254> 256320.5
JH387641616> 1280.50.50.250.5> 25640.5
EC463> 128648> 128164322> 256640.5
JH 4631286416> 12810.1250.1250.25> 2562< 0.25
EC7346488> 12816440.25> 256320.5
JH734641616> 1280.50.250.1250.5> 2562< 0.25
EC6113288> 12810.06250.06250.25> 25620.25
JH6116488> 1280.50.06250.1250.5> 25620.25
EC1441283232> 128> 128641280.25> 256320.5
JH1441281632> 1280.50.50.1250.5> 2562< 0.25
EC122> 1283264> 128> 12864> 2568> 2561280.5
JH1221281616> 1280.50.50.1250.5> 2562< 0.25
EC41832832> 12810.250.1251> 256480.5
JH41832816> 1280.50.250.1250.5> 2562< 0.25
CF41832328> 12810.250.l250.5> 25640.5
JHF4181688> 12810.250.1250.5> 2562< 0.25
EC310> 1281288> 128180.190.5> 25620.5
JHE310> 128648> 1280.50.50.1250.5> 2561< 0.25
EC6000.1250.580.250.50.1250.250.1250.51< 0.25
ATCC25922a0.1250.5< 80.1250.50.1250.1250.1250.250.25< 0.25

FEP cefepime, IMP imipenem, NIT nitrofurantoin, CAZ ceftazidime, AMK amikacin, CIP ciprofloxacin, ATM aztreonam, TGC tigecycline, MNO minocycline, CPS cefperazone/sulbactam, COL colistin

All susceptibility tests were repeated at least three times according to CLSI method. The results of colistin susceptibility were interpreted according to EUCAST breakpoints

aquality control strain

Antibiotic susceptibility of NMD5-producing isolates and their transconjugants FEP cefepime, IMP imipenem, NIT nitrofurantoin, CAZ ceftazidime, AMK amikacin, CIP ciprofloxacin, ATM aztreonam, TGC tigecycline, MNO minocycline, CPS cefperazone/sulbactam, COL colistin All susceptibility tests were repeated at least three times according to CLSI method. The results of colistin susceptibility were interpreted according to EUCAST breakpoints aquality control strain

Plasmid sequence analysis of blaNDM-5

The entire plasmid sequence was obtained to better characterize the blaNDM-5-positive plasmid. Sequence analysis showed that the plasmid was 46,145 bp in length (Fig. 3a). The blaNDM-5 gene was preceded by IS3000, ISAba125 and IS5, and followed by bleMBL, trpF, dsbC, IS6 and ISkox3.No other antimicrobial resistance genes were detected in this plasmid.
Fig. 3

Plasmid analysis of pEC463-NDM5. Schematic map of plasmid p pEC463-NDM5 (a), comparative analysis of three blaNDM-5-carrying IncX3 plasmids (b). The putative open reading frames are shown as arrowheads orrods (less than 130 amino acids). The gene name is shown near the corresponding arrowhead or rod. The depthof shading is indicative of the percentage BLASTN match, as indicated on the bottom

Plasmid analysis of pEC463-NDM5. Schematic map of plasmid p pEC463-NDM5 (a), comparative analysis of three blaNDM-5-carrying IncX3 plasmids (b). The putative open reading frames are shown as arrowheads orrods (less than 130 amino acids). The gene name is shown near the corresponding arrowhead or rod. The depthof shading is indicative of the percentage BLASTN match, as indicated on the bottom Further sequence alignments based on BLAST revealed that the plasmid sequences showed almost identical nucleotide sequences with those of the previously reported IncX3 plasmids pNDM-MGR194 of K. pneumoniae MGR-K194 in India [8]. The plasmid pNDM-MGR194 carrying blaNDM-5 was reported in 2015 in India, which was considered to play an important role in the dissemination of the blaNDM-5 gene because pNDM-MGR194-like plasmid was highly similar to those plasmids reported in China [3], Australia [5] and Denmark [7]. In addition, most of the blaNDM-5-carrying plasmids reported in China belonged to the IncX3-type and were identical or near-identical to pNDM-MGR194-like plasmid (Table 3). In this study, identification of the IncX3-type pNDM-MGR194-like plasmid in E. coli of different STs, K. pneumoniae and C. freundii strains indicated that this plasmid could mediate inter- and intra-species transfer of blaNDM-5. This possibility was further supported by our conjunction experimental data in vitro. Moreover, this plasmid carried in E. coli and C. freundii strains was isolated from faeces sample of a single patient at the same time, providing strong evidence that this plasmid could mediate blaNDM-5 dissemination in Enterobacteriaceae. Overall, our results revealed that IncX3-type pNDM-MGR194-like plasmids facilitate the rapid dissemination of blaNDM-5 among Enterobacteriaceae in China.
Table 3

Detailed information of the blaNDM-5-habouring plasmids reported in the NCBI database

Inc. groupTransferabilityaSize (kb)Host strainMLSTSampleCountryReference
IncX3T46b K. pneumoniae Human BloodIndia[8]
46b E. coli ST1284Human GroinDenmark[24]
46b E. coli ST648Human UrineIndia[5]
C46b E. coli ST167Human RectumChina[6]
C46b E. coli ST167Human UrineChina[30]
C46b E. coli ST167Human BloodChina[30]
C46b E. coli ST2608Human SwabChina[30]
C46b E. coli ST5131Human Vaginal secretionsChina[30]
T46b E. coli ST167Human sputumChina[3]
T46b E. coli ST167Human UrineChina[3]
T46b E. coli ST167Human BloodChina[21]
T46b E. coli ST167Human BloodChina[15]
T46b E. coli ST206Human stoolChina[31]
C46b K. michiganensis Human stoolChina[32]
C46b E. coli ST446Cows fecalChina[11]
C46b E. coli ST2Cows fecalChina[11]
C46b E. coli ST3Cows fecalChina[11]
C46b E. coli ST354Human ascitesChinathis study
C46b E. coli ST746Human fecesChinathis study
C46b E. coli ST6395Human bloodChinathis study
C46b E. coli ST6335Human pusChinathis study
C46b E. coli ST12Human ascitesChinathis study
46b E. coli ST410Human sputumChinathis study
C46b E. coli ST361Human bloodChinathis study
C46b E. coli ST167Human urineChinathis study
46b E. coli ST617Human UrineChinathis study
C46b K. pneumoniae Human bloodChinathis study
C46b C. freundii Human fecesChinathis study
IncF> 100 E. coli ST648Human throatUK[2]
T> 100 E. coli Human pusIndia[33]
T> 100 E. coli Human pusIndia[33]
IncFIIT84.5 Salmonella enterica serovar Typhimurium ST34Human fecalChina[34]
C110 E. coli ST418Human stoolPoland[35]
C90 E. coli ST418Human urineSpain[36]
IncNC110 E. coli ST540Human fecesJapan[37]
UntypeableC48 K. pneumoniae ST231Human urineSingapore[38]

aC: plasmid is able to transfer to E. coli recipients by conjugation; T: plasmid is able to transfer to E. coli recipients by transformation or electroporation

bThese plasmids are identical or near-identical to plasmid pNDM-MGR194

Detailed information of the blaNDM-5-habouring plasmids reported in the NCBI database aC: plasmid is able to transfer to E. coli recipients by conjugation; T: plasmid is able to transfer to E. coli recipients by transformation or electroporation bThese plasmids are identical or near-identical to plasmid pNDM-MGR194

Conclusions

We report a near-term epidemiological study demonstrating the further dissemination of Enterobacteriaceae with the blaNDM-5 gene in China. Our work provides evidence that the IncX3-type plasmid played an important role in the dissemination of blaNDM-5 in Enterobacteriaceae. In addition, to the best of our knowledge, this report is the first to isolate E. coli and C. freundii strains carrying blaNDM-5 from a single patient. Close surveillance is urgently needed to monitor the further spread of NDM-5-producing isolates. cg-MLST of blaNDM-5-positive isolates. (DOCX 61 kb)
  36 in total

1.  A novel variant, NDM-5, of the New Delhi metallo-β-lactamase in a multidrug-resistant Escherichia coli ST648 isolate recovered from a patient in the United Kingdom.

Authors:  Michael Hornsey; Lynette Phee; David W Wareham
Journal:  Antimicrob Agents Chemother       Date:  2011-09-19       Impact factor: 5.191

2.  Expansion of the IncX plasmid family for improved identification and typing of novel plasmids in drug-resistant Enterobacteriaceae.

Authors:  Timothy J Johnson; Eliza M Bielak; Daniela Fortini; Lars Hestbjerg Hansen; Henrik Hasman; Chitrita Debroy; Lisa K Nolan; Alessandra Carattoli
Journal:  Plasmid       Date:  2012-03-26       Impact factor: 3.466

3.  Detection of Klebsiella pneumoniae co-producing NDM-7 and OXA-181, Escherichia coli producing NDM-5 and Acinetobacter baumannii producing OXA-23 in a single patient.

Authors:  Anette M Hammerum; Pia Littauer; Frank Hansen
Journal:  Int J Antimicrob Agents       Date:  2015-08-18       Impact factor: 5.283

4.  Complete sequencing of an IncX3 plasmid carrying blaNDM-5 allele reveals an early stage in the dissemination of the blaNDM gene.

Authors:  M Krishnaraju; C Kamatchi; A K Jha; N Devasena; R Vennila; G Sumathi; R Vaidyanathan
Journal:  Indian J Med Microbiol       Date:  2015 Jan-Mar       Impact factor: 0.985

5.  Identification of plasmids by PCR-based replicon typing.

Authors:  Alessandra Carattoli; Alessia Bertini; Laura Villa; Vincenzo Falbo; Katie L Hopkins; E John Threlfall
Journal:  J Microbiol Methods       Date:  2005-06-02       Impact factor: 2.363

Review 6.  Carbapenemases in Klebsiella pneumoniae and other Enterobacteriaceae: an evolving crisis of global dimensions.

Authors:  L S Tzouvelekis; A Markogiannakis; M Psichogiou; P T Tassios; G L Daikos
Journal:  Clin Microbiol Rev       Date:  2012-10       Impact factor: 26.132

7.  Molecular characterization of blaNDM-5 carried on an IncFII plasmid in an Escherichia coli isolate from a nontraveler patient in Spain.

Authors:  Cristina Pitart; Mar Solé; Ignasi Roca; Angely Román; Asunción Moreno; Jordi Vila; Francesc Marco
Journal:  Antimicrob Agents Chemother       Date:  2014-10-13       Impact factor: 5.191

8.  Easyfig: a genome comparison visualizer.

Authors:  Mitchell J Sullivan; Nicola K Petty; Scott A Beatson
Journal:  Bioinformatics       Date:  2011-01-28       Impact factor: 6.937

9.  Dissemination of NDM-1-Producing Enterobacteriaceae Mediated by the IncX3-Type Plasmid.

Authors:  Qing Yang; Lanfang Fang; Ying Fu; Xiaoxing Du; Yuqin Shen; Yunsong Yu
Journal:  PLoS One       Date:  2015-06-05       Impact factor: 3.240

10.  First report of NDM-5-producing Escherichia coli ST1284 isolated from dog in Bejaia, Algeria.

Authors:  M Yousfi; A Mairi; S Bakour; A Touati; L Hassissen; L Hadjadj; J-M Rolain
Journal:  New Microbes New Infect       Date:  2015-09-10
View more
  34 in total

1.  Cross-Border Emergence of Escherichia coli Producing the Carbapenemase NDM-5 in Switzerland and Germany.

Authors:  Trinad Chakraborty; Mustafa Sadek; Yancheng Yao; Can Imirzalioglu; Roger Stephan; Laurent Poirel; Patrice Nordmann
Journal:  J Clin Microbiol       Date:  2021-02-18       Impact factor: 5.948

2.  Emergence of an NDM-5-Producing Hypervirulent Klebsiella pneumoniae Sequence Type 35 Strain with Chromosomal Integration of an Integrative and Conjugative Element, ICEKp1.

Authors:  Zhen Shen; Qianqian Gao; Juanxiu Qin; Yao Liu; Min Li
Journal:  Antimicrob Agents Chemother       Date:  2019-12-20       Impact factor: 5.191

Review 3.  NDM Metallo-β-Lactamases and Their Bacterial Producers in Health Care Settings.

Authors:  Wenjing Wu; Yu Feng; Guangmin Tang; Fu Qiao; Alan McNally; Zhiyong Zong
Journal:  Clin Microbiol Rev       Date:  2019-01-30       Impact factor: 26.132

4.  Epidemic IncX3 plasmids spreading carbapenemase genes in the United Arab Emirates and worldwide.

Authors:  Shaimaa F Mouftah; Tibor Pál; Dania Darwish; Akela Ghazawi; Laura Villa; Alessandra Carattoli; Ágnes Sonnevend
Journal:  Infect Drug Resist       Date:  2019-06-21       Impact factor: 4.003

5.  Detection and Genomic Characterization of a Morganella morganii Isolate From China That Produces NDM-5.

Authors:  Xiaobing Guo; Yuting Rao; Lihua Guo; Hao Xu; Tao Lv; Xiao Yu; Yunbo Chen; Na Liu; Huiming Han; Beiwen Zheng
Journal:  Front Microbiol       Date:  2019-05-28       Impact factor: 5.640

6.  Characterization of a novel bla NDM-5-harboring IncFII plasmid and an mcr-1-bearing IncI2 plasmid in a single Escherichia coli ST167 clinical isolate.

Authors:  Lijuan Xu; Ping Wang; Jing Cheng; Shangshang Qin; Weihong Xie
Journal:  Infect Drug Resist       Date:  2019-03-01       Impact factor: 4.003

7.  Emergence of IncX3 Plasmid-Harboring bla NDM- 5 Dominated by Escherichia coli ST48 in a Goose Farm in Jiangsu, China.

Authors:  Ziyi Liu; Xia Xiao; Yan Li; Yuan Liu; Ruichao Li; Zhiqiang Wang
Journal:  Front Microbiol       Date:  2019-09-04       Impact factor: 5.640

8.  uCARE Chem Suite and uCAREChemSuiteCLI: Tools for bacterial resistome prediction.

Authors:  Saurav Bhaskar Saha; Vijai Kumar Gupta; Pramod Wasudeo Ramteke
Journal:  Genes Dis       Date:  2020-06-30

9.  Detection and characterization of a clinical Escherichia coli ST3204 strain coproducing NDM-16 and MCR-1.

Authors:  Xi Li; Xinli Mu; Ping Zhang; Dongdong Zhao; Jingshu Ji; Jingjing Quan; Yongze Zhu; Yunsong Yu
Journal:  Infect Drug Resist       Date:  2018-08-15       Impact factor: 4.003

10.  High Prevalence of bla NDM Variants Among Carbapenem-Resistant Escherichia coli in Northern Jiangsu Province, China.

Authors:  Ruru Bi; Ziyan Kong; Huimin Qian; Fei Jiang; Haiquan Kang; Bing Gu; Ping Ma
Journal:  Front Microbiol       Date:  2018-11-13       Impact factor: 5.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.